| Zhang, Yu |
NCT06506838: Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma |
|
|
| Recruiting | 4 | 39 | RoW | Anlotinib | Guangdong Provincial People's Hospital | Soft Tissue Sarcoma, Doxorubicin, Radiotherapy | 07/27 | 07/28 | | |
| Not yet recruiting | 4 | 336 | RoW | Danning Tablet, Biliflow (NPN 80073325, manufactured by Shanghai Hutchison Pharmaceuticals Limited) | Eastern Hepatobiliary Surgery Hospital | Polyps Gallbladder | 08/24 | 11/24 | | |
NCT04683406: A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A |
|
|
| Completed | 3 | 750 | RoW | ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral), Placebo to ZSP1273 | Guangdong Raynovent Biotech Co., Ltd | Influenza A | 04/23 | 05/23 | | |
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure |
|
|
| Recruiting | 3 | 522 | RoW | D-1553 Tablet, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 10/26 | 12/27 | | |
| Recruiting | 3 | 516 | RoW | Tirofiban, Tirofiban Hydrochloride and Sodium Chloride Injection, Aspirin tablet, Clopidogrel tablet | Peking Union Medical College Hospital, Pharmaron (Chengdu) Clinical Services Co., Ltd. | Branch Atheromatous Disease | 07/25 | 10/25 | | |
| Active, not recruiting | 3 | 90 | Europe, Canada, US, RoW | Pimicotinib(ABSK021), Placebo | Abbisko Therapeutics Co, Ltd | Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath | 05/26 | 06/28 | | |
| Recruiting | 2/3 | 440 | RoW | Camrelizumab, Cisplatin, Nab paclitaxel, Radical surgery, external beam radiation therapy (EBRT) + brachytherapy | Tongji Hospital, Southwest Hospital, China, Women Hospital, School of Medicine, Zhejiang University, Anhui Provincial Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Qilu Hospital of Shandong University, Beijing Friendship Hospital, Tianjin Medical University General Hospital, West China Second University Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Xiangya Hospital of Central South University, Gansu Provincial Maternal and Child Health Care Hospital, Zhejiang Cancer Hospital, Shengjing Hospital, Cancer Hospital of Guangxi Medical University | Cervical Cancer, Locally Advanced Cervical Cancer, Concurrent Chemoradiotherapy, Neoadjuvant Chemoimmunotherapy | 03/31 | 03/31 | | |
TQB3616-ALTN-II-01, NCT04924192: A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer |
|
|
| Recruiting | 2 | 126 | RoW | TQB3616 capsules, Anlotinib Hydrochloride capsules, Irinotecan Hydrochloride for Injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Lung Carcinoma | 05/23 | 12/23 | | |
NCT05148195: A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors |
|
|
| Terminated | 2 | 86 | RoW | Envofolimab, BD0801, Docetaxel, Irinotecan, Leucovorin calcium, 5-Fluorouridine | Jiangsu Simcere Pharmaceutical Co., Ltd. | Advanced Solid Tumor | 07/23 | 07/23 | | |
NCT05765825: Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC |
|
|
| Recruiting | 2 | 61 | RoW | serplulimab, HLX10, Cisplatin, Cisplatin injection, Carboplatin, Carboplatin injection, Etoposide, Etoposide injection, Thoracic radiation therapy (TRT), low-dose radiotherapy | Sichuan University | Extensive-stage Small-cell Lung Cancer | 06/24 | 12/25 | | |
NCT06251947: Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen |
|
|
| Recruiting | 2 | 83 | RoW | Efbemalenograstim Alfa | Shandong University, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Ovarian Cancer, Cervical Cancer | 06/26 | 12/26 | | |
NCT06434610: A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. |
|
|
| Recruiting | 2 | 90 | RoW | B013, Paclitaxel, Placebo | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Platinum-resistant Recurrent Ovarian Cancer | 12/26 | 12/26 | | |
| Recruiting | 2 | 40 | RoW | Camrelizumab, SHR-1210, Paclitaxel-albumin, Injectable paclitaxel (albumin bound), Cisplatin, Cisplatin injection, radical surgery | Tongji Hospital, Southwest Hospital, China, Women Hospital, School of Medicine, Zhejiang University, Anhui Provincial Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Gansu Provincial Maternal and Child Health Care Hospital, Beijing Friendship Hospital, Tianjin Medical University General Hospital, Xiangya Hospital of Central South University, West China Second University Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Zhejiang Cancer Hospital, Shengjing Hospital, Qilu Hospital of Shandong University, Cancer Hospital of Guangxi Medical University | Cervical Cancer, Locally Advanced Cervical Cancer, PD-L1 Negative, Neoadjuvant Chemoimmunotherapy | 12/25 | 12/30 | | |
NCT06014190: HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer |
|
|
| Recruiting | 2 | 460 | RoW | HS-20089 | Hansoh BioMedical R&D Company | Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Endometrial Cancer | 12/25 | 12/27 | | |
NCT04202003: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
|
|
| Completed | 1/2 | 105 | RoW | TJ011133 | TJ Biopharma Co., Ltd. | Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes(MDS) | 12/23 | 12/23 | | |
|
|
NCT05767866: Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR |
|
|
| Recruiting | 1/2 | 160 | RoW | YK-029A | Suzhou Puhe Pharmaceutical Technology Co., LTD | Treatment, Treatment Side Effects | 12/23 | 05/24 | | |
NCT06118788: Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 1/2 | 24 | RoW | BG1805 | Guangzhou Bio-gene Technology Co., Ltd | Leukemia, Myeloid, Acute | 03/25 | 07/25 | | |
NCT05416775: Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 1/2 | 168 | RoW | SHR-8068；Adebrelimab, SHR-8068；adebrelimab and platinum-based chemotherapy, Adebrelimab；platinum-based chemotherapy | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Advanced Non-small Cell Lung Cancer | 06/26 | 06/26 | | |
NCT05788159: An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions. |
|
|
| Not yet recruiting | 1 | 16 | RoW | Lacosamide Tablets, Lacosamide extended release tablets | Overseas Pharmaceuticals, Ltd., Beijing Capton Pharmaceutical Technology Development Co., LTD | Epilepsy | 06/23 | 07/23 | | |
NCT06387082: A Clinical Study of HMPL-506 in Patients With Hematological Malignancies |
|
|
| Recruiting | 1 | 98 | RoW | HMPL-506, Two strengths of HMPL-506 tablets (25 mg and 100 mg) will be used for this clinical study | Hutchmed | Hematological Malignancies | 10/27 | 12/27 | | |
NCT06412458: IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma |
|
|
| Not yet recruiting | 1 | 9 | RoW | IM83 CAR-T Cells | Beijing Immunochina Medical Science & Technology Co., Ltd., Guangdong Provincial People's Hospital | Refractory Osteosarcoma, Recurrent Osteosarcoma | 06/25 | 06/26 | | |
NCT06662760: Clinical Trial of TQB3002 in Patients With Advanced Cancers |
|
|
| Not yet recruiting | 1 | 120 | RoW | TQB3002 Tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Cancer | 10/25 | 10/26 | | |
NCT05151133: Clinical Study of Allergic Rhinitis Therapy by Stem Cells |
|
|
| Recruiting | 1 | 18 | RoW | Low dose UCMSCs, Moderate dose UCMSCs, High dose UCMSCs | Yantai Yuhuangding Hospital | Allergic Rhinitis | 12/24 | 12/24 | | |
APG-115-AC101, NCT04275518: A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. |
|
|
| Recruiting | 1 | 102 | RoW | APG-115, Azacitidine, Cytarabine | Ascentage Pharma Group Inc., Suzhou Yasheng Pharmaceutical Co., Ltd. | Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) | 12/25 | 12/25 | | |
NCT04173832: Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine |
|
|
| Recruiting | N/A | 100 | RoW | Tianqi Pingchan Granule Combined With Amantadine, Placebo Combined With Amantadine | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Wenzhou Central Hospital, The Affiliated Hospital of Qingdao University, Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine, The Affiliated Hospital of Xuzhou Medical University | L-DOPA-Induced Dyskinesia | 12/20 | 12/21 | | |
NCT05233917: Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome |
|
|
| Completed | N/A | 240 | RoW | Olive oil use, MLCT oil use | Zhejiang University | Hyperlipidaemia, Metabolic Syndrome | 12/23 | 12/23 | | |
EBPS, NCT04809025: Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer |
|
|
| Recruiting | N/A | 510 | RoW | endoscopy, Surgery | Fudan University | Stomach Neoplasms, Endoscopy, Biopsy, Pathology | 04/23 | 04/24 | | |
PNFS, NCT05247632: Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study |
|
|
| Active, not recruiting | N/A | 2290 | RoW | | Zhejiang University, Lanxi Red Cross Hospital, Lanxi Hospital of Traditional Chinese Medicine | Chronic Diseases | 05/24 | 07/28 | | |
NCT06039735: Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma |
|
|
| Recruiting | N/A | 50 | RoW | Chemotherapy and/or autologous hematopoietic stem cell transplantation | Qilu Hospital of Shandong University | Multiple Myeloma | 11/23 | 12/28 | | |
NCT06512207: A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer |
|
|
| Recruiting | N/A | 80 | RoW | Leuprorelin acetate + Sintilimab, Leuprolide, Sintilimab, Anti-PD-1 monoclonal | Jinzhou Medical University, The First Affiliated Hospital of Zhengzhou University | NSCLC, Stage III, NSCLC, Stage IV | 12/25 | 06/26 | | |
| Recruiting | N/A | 590 | RoW | Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy | Women's Hospital School Of Medicine Zhejiang University, Tongji Hospital, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, Sun Yat-sen University, Peking University People's Hospital, Shanghai First Maternity and Infant Hospital, Xiangya Hospital of Central South University, Anhui Provincial Cancer Hospital, Ningbo Women & Children's Hospital, Ningbo No. 1 Hospital | Endometrial Cancer Stage I, Endometrial Cancer Stage II | 12/24 | 01/27 | | |
NCT06276309: Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors |
|
|
| Recruiting | N/A | 300 | RoW | | Fujian Maternity and Child Health Hospital | Neuroendocrine Neoplasm, China, Women, Cervical Cancer, Cervical Lesion | 12/24 | 02/25 | | |
NCT06717178: Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China |
|
|
| Not yet recruiting | N/A | 322 | RoW | Chemotherapy | RenJi Hospital | Cancer, Cancer-related Problem/Condition | 12/25 | 12/25 | | |
NCT05932576: A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women |
|
|
| Recruiting | N/A | 12000 | RoW | | Fujian Maternity and Child Health Hospital | Human Papillomavirus Vaccines, Efficacy, Self, Adverse Effect, China, Woman | 12/24 | 12/24 | | |
NCT05932563: Study on the Epidemiological Characteristics of Female HPV Vaccination in China |
|
|
| Recruiting | N/A | 1700 | RoW | | Fujian Maternity and Child Health Hospital | Human Papillomavirus Vaccines, Adverse Effect, Epidemiology, China, Woman | 12/24 | 12/24 | | |
| Hu, Yan-Ling |
| No trials found |
